Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 360

1.

Experimental study of coil delivery wire insertion force in intracranial aneurysm embolization: force discrepancy generated inside the microcatheter through that coil delivery wire passes.

Shintai K, Matsubara N, Izumi T, Miyachi S, Yamada H, Marui N, Wakabayashi T.

Nagoya J Med Sci. 2019 May;81(2):217-225. doi: 10.18999/nagjms.81.2.217.

2.

Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors.

Doi T, Fujiwara Y, Matsubara N, Tomomatsu J, Iwasa S, Tanaka A, Endo-Tsukude C, Nakagawa S, Takahashi S.

Cancer Chemother Pharmacol. 2019 Aug;84(2):393-404. doi: 10.1007/s00280-019-03882-7. Epub 2019 Jun 21.

PMID:
31227862
3.

Repair of an Osteochondral Defect With Minced Cartilage Embedded in Atelocollagen Gel: A Rabbit Model.

Matsushita R, Nakasa T, Ishikawa M, Tsuyuguchi Y, Matsubara N, Miyaki S, Adachi N.

Am J Sports Med. 2019 Jul;47(9):2216-2224. doi: 10.1177/0363546519854372. Epub 2019 Jun 17.

PMID:
31206306
4.

Evaluation and Optimization of a New PET Reconstruction Algorithm, Bayesian Penalized Likelihood Reconstruction, for Lung Cancer Assessment According to Lesion Size.

Otani T, Hosono M, Kanagaki M, Onishi Y, Matsubara N, Kawabata K, Kimura H.

AJR Am J Roentgenol. 2019 Apr 17:1-7. doi: 10.2214/AJR.18.20478. [Epub ahead of print]

PMID:
30995096
5.

Placement of a Viabahn stent-graft for hepatic artery pseudoaneurysm complicated by arterial dissection caused by a guiding sheath.

Onishi Y, Kimura H, Kanagaki M, Oka S, Fukumoto G, Otani T, Matsubara N, Kawabata K.

Radiol Case Rep. 2019 Apr 2;14(6):711-713. doi: 10.1016/j.radcr.2019.03.021. eCollection 2019 Jun.

6.

Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.

Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, Özgüroğlu M, Ye D, Feyerabend S, Protheroe A, Sulur G, Luna Y, Li S, Mundle S, Chi KN.

Lancet Oncol. 2019 May;20(5):686-700. doi: 10.1016/S1470-2045(19)30082-8. Epub 2019 Apr 12.

PMID:
30987939
7.

Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.

Uemura H, Uemura H, Nagamori S, Wakumoto Y, Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T, Matsubara N.

Int J Clin Oncol. 2019 May;24(5):557-566. doi: 10.1007/s10147-018-01389-4. Epub 2019 Mar 14.

8.

Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide.

Kumano Y, Hasegawa Y, Kawahara T, Yasui M, Miyoshi Y, Matsubara N, Uemura H.

Biomed Res Int. 2019 Jan 20;2019:9450838. doi: 10.1155/2019/9450838. eCollection 2019.

9.

Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.

Smith M, Parker C, Saad F, Miller K, Tombal B, Ng QS, Boegemann M, Matveev V, Piulats JM, Zucca LE, Karyakin O, Kimura G, Matsubara N, Nahas WC, Nolè F, Rosenbaum E, Heidenreich A, Kakehi Y, Zhang A, Krissel H, Teufel M, Shen J, Wagner V, Higano C.

Lancet Oncol. 2019 Mar;20(3):408-419. doi: 10.1016/S1470-2045(18)30860-X. Epub 2019 Feb 6.

PMID:
30738780
10.

Mechanism Underlying Organophosphate Paraoxon-Induced Kinetic Tremor.

Iha HA, Kunisawa N, Shimizu S, Onishi M, Nomura Y, Matsubara N, Iwai C, Ogawa M, Hashimura M, Sato K, Kato M, Ohno Y.

Neurotox Res. 2019 Apr;35(3):575-583. doi: 10.1007/s12640-019-0007-7. Epub 2019 Feb 7.

PMID:
30729450
11.

[A Case of Locally Advanced Sigmoid Colon Cancer Occupying the Pelvis with Successful Total Posterior Pelvic Exenteration after Triplet Chemotherapy].

Maeda T, Hamanaka H, Sanada Y, Hirata A, Beppu N, Kihara N, Hiraoka K, Matsubara N.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2048-2050. Japanese.

PMID:
30692280
12.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Mar 1;37(7):570-579. doi: 10.1200/JCO.18.00771. Epub 2019 Jan 17.

PMID:
30653423
13.

Individualized Dosing of Axitinib Based on First-Dose Area Under the Concentration-Time Curve for Metastatic Renal-Cell Carcinoma.

Miura Y, Imamura CK, Uchino K, Kishida T, Matsubara N, Shinojima T, Kondo K, Hongo F, Yoshimura K, Tanigawara Y, Takano T.

Clin Genitourin Cancer. 2019 Feb;17(1):e1-e11. doi: 10.1016/j.clgc.2018.09.015. Epub 2018 Sep 29.

PMID:
30529389
14.

Loop formation by an aortic occlusion balloon catheter during resuscitative endovascular balloon occlusion of the aorta (REBOA).

Onishi Y, Kimura H, Kanagaki M, Oka S, Fukumoto G, Otani T, Matsubara N, Kawabata K, Matsumoto M, Suzuki T.

Radiol Case Rep. 2018 Nov 6;14(2):184-186. doi: 10.1016/j.radcr.2018.10.018. eCollection 2019 Feb.

15.
16.

Usefulness of a distal access catheter in embolization of a short gastric artery pseudoaneurysm.

Onishi Y, Kimura H, Kanagaki M, Oka S, Fukumoto G, Otani T, Matsubara N, Kawabata K, Namikawa M, Kimura T.

Radiol Case Rep. 2018 Oct 17;14(1):69-71. doi: 10.1016/j.radcr.2018.09.019. eCollection 2019 Jan.

17.

Successful embolization of ileal conduit stomal varices with N-butyl cyanoacrylate via a recanalized paraumbilical vein.

Onishi Y, Kimura H, Kanagaki M, Oka S, Fukumoto G, Otani T, Matsubara N, Kawabata K, Yasufuku T, Yamada Y.

Radiol Case Rep. 2018 Sep 13;13(6):1130-1132. doi: 10.1016/j.radcr.2018.07.024. eCollection 2018 Dec.

18.

Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review.

Sada H, Hinoi T, Ueno H, Yamaguchi T, Inoue Y, Konishi T, Kobayashi H, Kanemitsu Y, Ishida F, Ishida H, Tomita N, Matsubara N, Sugihara K.

Surg Today. 2019 Jan;49(1):72-81. doi: 10.1007/s00595-018-1710-3. Epub 2018 Sep 4.

PMID:
30182306
19.

Preliminary Kidney Parenchymal Ligation Using Endoloop Ligatures-A Simple Method to Achieve a Trifecta in Laparoscopic Partial Nephrectomy Without Hilar Clamping for Polar Complex Tumors.

Komai Y, Gotohda N, Matsubara N, Takeda H, Yuasa T, Inoue M, Yamamoto S, Yonese J.

Urology. 2018 Nov;121:182-188. doi: 10.1016/j.urology.2018.08.023. Epub 2018 Aug 29.

PMID:
30171918
20.

Lenvatinib in combination with everolimus in patients with advanced or metastatic renal cell carcinoma: A phase 1 study.

Matsubara N, Naito Y, Nakano K, Fujiwara Y, Ikezawa H, Yusa W, Namiki M, Okude T, Takahashi S.

Int J Urol. 2018 Nov;25(11):922-928. doi: 10.1111/iju.13776. Epub 2018 Aug 20.

PMID:
30129060
21.

Dose-finding study of the checkpoint kinase 1 inhibitor, prexasertib, in Japanese patients with advanced solid tumors.

Iwasa S, Yamamoto N, Shitara K, Tamura K, Matsubara N, Tajimi M, Lin AB, Asou H, Cai Z, Inoue K, Shibasaki Y, Saito K, Takai H, Doi T.

Cancer Sci. 2018 Oct;109(10):3216-3223. doi: 10.1111/cas.13750.

22.

Experimental study of the characteristics of various types of filling coils for intracranial aneurysm embolisation.

Ito M, Matsubara N, Izumi T, Miyachi S, Ota K, Imai T, Nishihori M, Wakabayashi T.

Interv Neuroradiol. 2018 Oct;24(5):513-519. doi: 10.1177/1591019918779196. Epub 2018 Jun 19.

PMID:
29921151
23.

High-resolution cone beam CT for evaluation of vascular channel in intracranial partial thrombosed aneurysm.

Shintai K, Matsubara N, Izumi T.

Nagoya J Med Sci. 2018 May;80(2):279-284. doi: 10.18999/nagjms.80.2.279.

24.

Association between CYP2C19 genotype and the additional effect of cilostazol to clopidogrel resistance in neuroendovascular therapy.

Tajima H, Izumi T, Miyachi S, Matsubara N, Ito M, Imai T, Nishihori M, Shintai K, Okamoto S, Araki Y, Kumakura Y, Furukawa-Hibi Y, Yamada K, Wakabayashi T.

Nagoya J Med Sci. 2018 May;80(2):207-215. doi: 10.18999/nagjms.80.2.207.

25.

Postoperative complications after stapled and hand-sewn ileal pouch-anal anastomosis for familial adenomatous polyposis: A multicenter study.

Konishi T, Ishida H, Ueno H, Kobayashi H, Hinoi T, Inoue Y, Ishida F, Kanemitsu Y, Yamaguchi T, Tomita N, Matsubara N, Watanabe T, Sugihara K.

Ann Gastroenterol Surg. 2017 Jul 20;1(2):143-149. doi: 10.1002/ags3.12019. eCollection 2017 Jun.

26.

Possibility of Interstitial Lung Disease as a Phlebosclerotic Colitis Manifestation.

Takemura T, Kataoka Y, Iki R, Nishioka Y, Matsubara N, Kanagaki M, Yasumizu Y.

Case Rep Gastroenterol. 2018 Apr 24;12(1):182-188. doi: 10.1159/000488525. eCollection 2018 Jan-Apr.

27.

Method for Catalytic Enantioselective Alkylation of Aldehydes Using Grignard Reagents as Alkyl Sources.

Tanaka K, Tomihama M, Yamamoto K, Matsubara N, Harada T.

J Org Chem. 2018 Jun 1;83(11):6127-6132. doi: 10.1021/acs.joc.8b00929. Epub 2018 May 16.

PMID:
29745658
28.

CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.

Matsubara N, Imamura A, Yonemizu T, Akatsu C, Yang H, Ueki A, Watanabe N, Abdu-Allah H, Numoto N, Takematsu H, Kitazume S, Tedder TF, Marth JD, Ito N, Ando H, Ishida H, Kiso M, Tsubata T.

Front Immunol. 2018 Apr 19;9:820. doi: 10.3389/fimmu.2018.00820. eCollection 2018.

29.

Successful Embolization of Bleeding Ileal Varices with N-butyl Cyanoacrylate via a Recanalized Paraumbilical Vein.

Onishi Y, Kimura H, Kanagaki M, Oka S, Fukumoto G, Otani T, Matsubara N, Kawabata K, Namikawa M, Matsumura T, Kimura T.

Cardiovasc Intervent Radiol. 2018 Aug;41(8):1291-1294. doi: 10.1007/s00270-018-1970-8. Epub 2018 Apr 23.

PMID:
29687259
30.

Alcohol consumption and early-onset risk of colorectal cancer in Japanese patients with Lynch syndrome: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.

Miguchi M, Hinoi T, Tanakaya K, Yamaguchi T, Furukawa Y, Yoshida T, Tamura K, Sugano K, Ishioka C, Matsubara N, Tomita N, Arai M, Ishikawa H, Hirata K, Saida Y, Ishida H, Sugihara K.

Surg Today. 2018 Aug;48(8):810-814. doi: 10.1007/s00595-018-1654-7. Epub 2018 Mar 24.

PMID:
29574523
31.

Baseline neutrophil-to-lymphocyte ratio predicts the prognosis of castration-resistant prostate cancer treated with abiraterone acetate.

Yasui M, Hasegawa Y, Kawahara T, Kumano Y, Miyoshi Y, Matsubara N, Uemura H.

Mol Clin Oncol. 2018 Apr;8(4):592-594. doi: 10.3892/mco.2018.1573. Epub 2018 Feb 13.

32.

Treatment with escitalopram modulates cardiovascular function in rats.

Veríssimo LF, Volpini VL, Estrada VB, Matsubara NK, Gomes MV, Resstel LBM, Correa FMA, Pelosi GG.

Eur J Pharmacol. 2018 Apr 5;824:120-127. doi: 10.1016/j.ejphar.2018.02.003. Epub 2018 Feb 8.

PMID:
29428469
33.

Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling.

Fujita M, Matsubara N, Matsuda I, Maejima K, Oosawa A, Yamano T, Fujimoto A, Furuta M, Nakano K, Oku-Sasaki A, Tanaka H, Shiraishi Y, Mateos RN, Nakai K, Miyano S, Tomita N, Hirota S, Ikeuchi H, Nakagawa H.

Oncotarget. 2017 Dec 12;9(1):969-981. doi: 10.18632/oncotarget.22867. eCollection 2018 Jan 2.

34.
35.

Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.

Chi KN, Protheroe A, Rodríguez-Antolín A, Facchini G, Suttman H, Matsubara N, Ye Z, Keam B, Damião R, Li T, McQuarrie K, Jia B, De Porre P, Martin J, Todd MB, Fizazi K.

Lancet Oncol. 2018 Feb;19(2):194-206. doi: 10.1016/S1470-2045(17)30911-7. Epub 2018 Jan 8.

PMID:
29326030
36.

Tracheoesophageal diversion and puncture operation for intractable aspiration: A case series.

Umezaki T, Adachi K, Matsubara N, Lee Y.

Laryngoscope. 2018 Aug;128(8):1791-1794. doi: 10.1002/lary.27039. Epub 2018 Jan 4. No abstract available.

PMID:
29314039
37.

Evaluation for shunted pouches of cavernous sinus dural arteriovenous fistula and the treatment outcome of transvenous embolization.

Sato M, Izumi T, Matsubara N, Nishihori M, Miyachi S, Wakabayashi T.

Interv Neuroradiol. 2018 Apr;24(2):189-196. doi: 10.1177/1591019917743064. Epub 2017 Nov 29.

38.

Ir4(CO)12-Catalyzed Benzylic C(sp3)-H Silylation of 2-Alkylpyridines with Hydrosilanes Leading to 2-(1-Silylalkyl)pyridines.

Fukumoto Y, Hirano M, Matsubara N, Chatani N.

J Org Chem. 2017 Dec 15;82(24):13649-13655. doi: 10.1021/acs.joc.7b02375. Epub 2017 Nov 30.

PMID:
29131615
39.

Contrast-induced Encephalopathy Following Embolization of Intracranial Aneurysms in Hemodialysis Patients.

Matsubara N, Izumi T, Miyachi S, Ota K, Wakabayashi T.

Neurol Med Chir (Tokyo). 2017 Dec 15;57(12):641-648. doi: 10.2176/nmc.oa.2017-0132. Epub 2017 Oct 31.

40.

Erratum to: Phase 1 study of darolutamide (ODM-201), a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer.

Matsubara N, Mukai H, Hosono A, Onomura M, Sasaki M, Yajima Y, Hashizume K, Yasuda M, Uemura M, Zurth C.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1073-1077. doi: 10.1007/s00280-017-3433-3. No abstract available.

PMID:
29063294
41.

Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer.

Matsubara N, Yamada Y, Tabata KI, Satoh T, Kamiya N, Suzuki H, Kawahara T, Uemura H, Yano A, Kawakami S, Otsuka M, Fukasawa S.

Clin Genitourin Cancer. 2018 Apr;16(2):142-148. doi: 10.1016/j.clgc.2017.09.008. Epub 2017 Sep 23.

PMID:
29042308
42.

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study.

Doi T, Shitara K, Naito Y, Shimomura A, Fujiwara Y, Yonemori K, Shimizu C, Shimoi T, Kuboki Y, Matsubara N, Kitano A, Jikoh T, Lee C, Fujisaki Y, Ogitani Y, Yver A, Tamura K.

Lancet Oncol. 2017 Nov;18(11):1512-1522. doi: 10.1016/S1470-2045(17)30604-6. Epub 2017 Oct 13.

PMID:
29037983
43.

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial.

Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain S, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Hegemann M, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Del Muro XG, Rodriguez-Vida A, Cicin I, Harputluoglu H, Widau RC, Liepa AM, Walgren RA, Hamid O, Zimmermann AH, Bell-McGuinn KM, Powles T; RANGE study investigators.

Lancet. 2017 Nov 18;390(10109):2266-2277. doi: 10.1016/S0140-6736(17)32365-6. Epub 2017 Sep 12.

PMID:
28916371
44.

Comparison of Sequential Treatment With Androgen Receptor-Targeted Agent Followed by Another Androgen Receptor-Targeted Agent Versus Androgen Receptor-Targeted Agent Followed by Docetaxel in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer.

Matsubara N, Yamada Y, Tabata KI, Satoh T, Kamiya N, Suzuki H, Kawahara T, Uemura H, Yano A, Kawakami S, Otsuka M, Fukasawa S.

Clin Genitourin Cancer. 2017 Dec;15(6):e1073-e1080. doi: 10.1016/j.clgc.2017.07.016. Epub 2017 Jul 26.

PMID:
28826931
45.

Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer.

Matsubara N, Mukai H, Hosono A, Onomura M, Sasaki M, Yajima Y, Hashizume K, Yasuda M, Uemura M, Zurth C.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1063-1072. doi: 10.1007/s00280-017-3417-3. Epub 2017 Aug 11. Erratum in: Cancer Chemother Pharmacol. 2017 Oct 23;:.

46.

Mn2TeO6: a Distorted Inverse Trirutile Structure.

Matsubara N, Damay F, Vertruyen B, Barrier N, Lebedev OI, Boullay P, Elkaïm E, Manuel P, Khalyavin DD, Martin C.

Inorg Chem. 2017 Aug 21;56(16):9742-9753. doi: 10.1021/acs.inorgchem.7b01269. Epub 2017 Aug 7.

47.

Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.

Matsubara N, Nagamori S, Wakumoto Y, Uemura H, Kimura G, Yokomizo A, Kikukawa H, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Tsutsui H, Uemura H.

Int J Clin Oncol. 2018 Feb;23(1):173-180. doi: 10.1007/s10147-017-1176-0. Epub 2017 Aug 2.

48.

Serotonergic modulation of nicotine-induced kinetic tremor in mice.

Kunisawa N, Iha HA, Nomura Y, Onishi M, Matsubara N, Shimizu S, Ohno Y.

J Pharmacol Sci. 2017 Jun;134(2):131-138. doi: 10.1016/j.jphs.2017.06.001. Epub 2017 Jun 9.

49.

Clinical Application of Insertion Force Sensor System for Coil Embolization of Intracranial Aneurysms.

Matsubara N, Miyachi S, Izumi T, Yamada H, Marui N, Ota K, Tajima H, Shintai K, Ito M, Imai T, Nishihori M, Wakabayashi T.

World Neurosurg. 2017 Sep;105:857-863. doi: 10.1016/j.wneu.2017.06.092. Epub 2017 Jun 21.

PMID:
28645602
50.

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.

Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, Özgüroğlu M, Ye D, Feyerabend S, Protheroe A, De Porre P, Kheoh T, Park YC, Todd MB, Chi KN; LATITUDE Investigators.

N Engl J Med. 2017 Jul 27;377(4):352-360. doi: 10.1056/NEJMoa1704174. Epub 2017 Jun 4.

Supplemental Content

Loading ...
Support Center